FDA Inspection 1054757 — Blistex Inc
The FDA completed an inspection of Blistex Inc on May 10, 2018 in Oak Brook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Oak Brook, IL (United States)